These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 23380947)

  • 1. The final word on proton pump inhibitors and osteoporosis?
    Gerson LB
    Gastroenterology; 2013 Mar; 144(3):650-2. PubMed ID: 23380947
    [No Abstract]   [Full Text] [Related]  

  • 2. Bariatric surgery, proton pump inhibitors, and possibility of osteoporosis.
    Deitel M
    Surg Obes Relat Dis; 2010; 6(4):461-2. PubMed ID: 20655033
    [No Abstract]   [Full Text] [Related]  

  • 3. Proton pump inhibitors, osteoporosis, and osteoporosis-related fractures.
    Fournier MR; Targownik LE; Leslie WD
    Maturitas; 2009 Sep; 64(1):9-13. PubMed ID: 19674854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton pump inhibitor therapy predisposes to community-acquired Streptococcus pneumoniae pneumonia.
    de Jager CP; Wever PC; Gemen EF; van Oijen MG; van Gageldonk-Lafeber AB; Siersema PD; Kusters GC; Laheij RJ
    Aliment Pharmacol Ther; 2012 Nov; 36(10):941-9. PubMed ID: 23034135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: the clinical pharmacology of proton pump inhibitors.
    Sachs G; Shin JM; Howden CW
    Aliment Pharmacol Ther; 2006 Jun; 23 Suppl 2():2-8. PubMed ID: 16700898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The early effect of proton pump inhibitor therapy on the accuracy of the 13C-urea breath test.
    Mana F; Van Laer W; Bossuyt A; Urbain D
    Dig Liver Dis; 2005 Jan; 37(1):28-32. PubMed ID: 15702856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence and adherence to proton pump inhibitors in daily clinical practice.
    Van Soest EM; Siersema PD; Dieleman JP; Sturkenboom MC; Kuipers EJ
    Aliment Pharmacol Ther; 2006 Jul; 24(2):377-85. PubMed ID: 16842465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Are proton pump inhibitors superior to H2 receptor antagonists within the scope of H. pylori eradication therapy? Meta analysis of current parallel group comparisons].
    Holtmann G; Layer P; Goebell H
    Z Gastroenterol; 1996 May; 34(5):267-72. PubMed ID: 8686357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review article: the pharmacodynamics and pharmacokinetics of proton pump inhibitors--overview and clinical implications.
    Robinson M
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 6():1-10. PubMed ID: 15496213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescribing of anti-osteoporotic therapies following the use of proton pump inhibitors in general practice.
    McGowan B; Bennett K; Barry M
    Pharmacoepidemiol Drug Saf; 2010 Jul; 19(7):763-9. PubMed ID: 20582909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton pump inhibitors and the time trends for esophageal dilation.
    Guda NM; Vakil N
    Am J Gastroenterol; 2004 May; 99(5):797-800. PubMed ID: 15128339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rabeprazole: the role of proton pump inhibitors in Helicobacter pylori eradication.
    Sharara AI
    Expert Rev Anti Infect Ther; 2005 Dec; 3(6):863-70. PubMed ID: 16307499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An unknown but potentially serious side effect of proton pump inhibitors: hypomagnesaemia].
    Doornebal J; Bijlsma R; Brouwer RM
    Ned Tijdschr Geneeskd; 2009; 153():A711. PubMed ID: 19930736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug-induced osteoporosis].
    Briot K
    Rev Prat; 2012 Feb; 62(2):187-92. PubMed ID: 22408857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
    Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
    Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence.
    Cooper BT; Chapman W; Neumann CS; Gearty JC
    Aliment Pharmacol Ther; 2006 Mar; 23(6):727-33. PubMed ID: 16556174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis: proton-pump inhibition in high-risk patients with acute peptic ulcer bleeding.
    Bardou M; Toubouti Y; Benhaberou-Brun D; Rahme E; Barkun AN
    Aliment Pharmacol Ther; 2005 Mar; 21(6):677-86. PubMed ID: 15771753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of intragastric acidity during post-breakfast and pre-dinner administration of low-dose proton pump inhibitors: a randomized three-way crossover study.
    Miki M; Adachi K; Azumi T; Koshino K; Furuta K; Kinoshita Y
    Aliment Pharmacol Ther; 2006 Nov; 24(10):1445-51. PubMed ID: 17032285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clostridium difficile infection and proton pump inhibitors.
    Pohl JF
    Curr Opin Pediatr; 2012 Oct; 24(5):627-31. PubMed ID: 22781139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Side effects of proton pump inhibitors (PPIs)].
    Maffei M; Desmeules J; Cereda JM; Hadengue A
    Rev Med Suisse; 2007 Sep; 3(123):1934-6, 1938. PubMed ID: 17918487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.